Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sun Pharma shares in spotlight
India's Sun Pharma beats Q2 profit view on higher demand for specialty drugs
Sun Pharmaceuticals , India's largest drugmaker by revenue, reported second-quarter profit above analysts' estimates on Monday, aided by higher demand for its specialty drugs that are used to treat uncommon medical conditions.
Sun Pharma shares in spotlight after Q2 profit rises 28% YoY to Rs 3,040 crore. Should you invest?
Sun Pharma shares are poised for attention on Tuesday after the company reported a 28% YoY growth in consolidated net profit, reaching Rs 3,040 crore in the second quarter. Revenue from operations rose by 9% YoY to Rs 13,
Sun Pharma Share Price Rises As Analysts Find Q2 Earnings More Resilient Than Peers
Most brokerages retained ratings and target prices for Sun Pharmaceutical Industries after its second quarter earnings beat estimates.
India's Sun Pharma beats Q2 profit estimates on strong sales
Sun Pharmaceuticals, India's largest drugmaker by revenue, reported second-quarter profit above analysts' estimates on Monday, aided by strong sales of its specialty drugs that are used to treat uncommon medical conditions.
Sun Pharma's Q2 Profit Surges, Plans Strategic Expansion
Sun Pharmaceutical Industries has reported a notable 28% increase in its consolidated net profit, amounting to Rs 3,040 crore for the September quarter. This rise in profit underscores the company's growth trajectory and strategic commercial agreements to expand its specialty product offerings.
Sun Pharma’s Q2 net profit jumps 28% on-year to Rs 3,040 crore, beats expectations
Analysts expected India's largest drugmaker's net profit to jump, led by favourable seasonality and strong specialty sales.
Sun Pharma profit up 28% on higher sales
Sun Pharma reported a 28% increase in consolidated net profit for the second quarter ended September, at Rs 3,040 crore, with sales up by 9% to Rs 13,291 crore. The performance was buoyed by robust sales in its main markets,
Sun Pharma Q2 Results: Net profit rises 28% YoY at ₹3,040.16 crore
Sun Pharmaceutical Industries Ltd on Monday reported an 28% year-on-year rise in its consolidated net profit for the fiscal's second quarter ended September (Q2FY24) to ₹3,040.16 crore. The company had reported a profit of ₹23,
2d
on MSN
Sun Pharma Q2 Results Preview: PAT likely to grow 11.5%; gross margin may improve
Led by growth in its domestic business, the specialty generic pharma company is expected to post good July-September quarter.
11h
Sun Pharma Stocks: Sun Pharma's Stock Update
Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...
2d
Sun Pharma’s hair loss drug Leqselvi's launch remains in limbo
Leqselvi, projected to generate around $200 million in sales over the next three to four years for Sun Pharma, was slated for ...
Daily
20h
Sun Pharma Winlevi cream 1% reduces Sebum levels, suitable for combination with other commonly used topical acne medications: Study
Mumbai: Sun Pharmaceutical Industries Limited has presented data strengthening the clinical rationale for the use of WINLEVI (clascoterone) cream 1% to treat acne. In poster presentations at ...
2d
Sun Pharma Highlights: Sun Pharma Stock Price History
Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...
ndtvprofit
1d
Sun Pharma Q2 Results Review - Dolat Capital Sees Limited Upside, Maintains 'Reduce' Rating
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s ...
devdiscourse
1d
Pharma & Food Giants Face Critical Scrutiny Amid Market Moves
Recent health industry updates reveal Sun Pharma's profit surge due to specialty drugs, Pfizer's strategic focus under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
India
Catalent
Roche
RS Components
Feedback